⚠️ Not Legal Advice

This page is for educational purposes only and does not constitute legal advice. Drug laws change frequently, and Ireland's Citizens' Assembly on Drugs Use recommended reform in 2023 that could plausibly change this picture β€” always verify the current status directly with the Irish Department of Health or the Health Products Regulatory Authority (https://www.gov.ie) or a qualified Irish solicitor before making any decisions.

Last reviewed: July 2026. This entry is drawn from Psilobase's broader Legal Status by Country guide. Because psilocybin law is an actively moving target worldwide, treat any date-stamped legal claim — including this one — as needing re-verification if you are reading it more than a few months after the review date above.

Quick Answer

Psilocybin is a Schedule 1 controlled drug in Ireland under the Misuse of Drugs Acts 1977–2016 β€” broadly equivalent in severity to Class A classification in the neighbouring UK. Ireland has one of the stricter drug enforcement environments in Western Europe: possession can lead to up to 7 years' imprisonment, and possession with intent to supply, or supply itself, can carry an unlimited (effectively life) sentence. There is no decriminalisation, medical access programme, or tolerated retail channel for psilocybin in Ireland as of 2026, though official reform discussion is further along than in many comparable countries.

Current Legal Status in Ireland

Under the Misuse of Drugs Acts, psilocybin and psilocybin-containing mushrooms are Schedule 1 substances. Simple possession can attract penalties of up to 7 years' imprisonment along with an unlimited fine, though sentencing in practice varies considerably with quantity, prior record, and judicial discretion β€” first-time possession of a very small personal amount is not automatically treated at the statutory maximum. Possession with intent to supply, or supply/sale itself, is prosecuted far more severely and can, at the upper end, carry an unlimited prison sentence (effectively life) plus unlimited fines for serious trafficking. There is no diversion-to-treatment scheme built into Irish law comparable to Portugal's Dissuasion Commissions or Austria's SS 35-37 SMG, though GardaΓ­ (Irish police) and prosecutors retain some discretion in minor cases. Research involving psilocybin is possible in principle via Health Products Regulatory Authority (HPRA) and Misuse of Drugs licensing, but remains rare and tightly restricted, with no large-scale Irish clinical trial programme comparable to the UK's or Germany's as of 2026.

History: How the Law Got Here

Ireland's Misuse of Drugs Act 1977, as amended through 2016, established the current Schedule 1-5 classification system, closely modelled on β€” and comparably strict to β€” the UK's Misuse of Drugs Act 1971. Ireland's approach to drug policy reform has moved cautiously: a national Citizens' Assembly on Drugs Use was convened and reported in 2023–2024, ultimately recommending a shift toward a health-led rather than purely criminal-justice approach to personal drug use, including forms of decriminalisation. This recommendation has been publicly discussed by government but had not been translated into legislation as of 2026, meaning psilocybin's Schedule 1 status and associated criminal penalties remain formally unchanged even as the political conversation continues. Ireland has also not followed Germany's 2024 cannabis reform with any parallel psychedelic-specific initiative.

How to Verify This Yourself

Laws referenced on this page were last reviewed in July 2026. Before making any decision based on legal status, check directly with the Irish Department of Health: https://www.gov.ie, and watch for any legislative follow-through on the Citizens' Assembly on Drugs Use recommendations, which could change this entry materially. For broader cross-country comparison and additional official sources, see the full Legal Status by Country guide.

Related Country Guides

Related Legal Topics